Clinical Trials Targeting Secondary Damage after Traumatic Spinal Cord Injury is a research paper published in International Journal of Molecular Sciences (2023). On theSindex it has a DataRank of 0.574. It has been cited 45 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.574
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIH
Grant: R01NS121191
NIH
Grant: R03AG073929
NIH
Grant: R01CA241927
NIH
Grant: 725788
National Institutes of Health
Grant: 1R01CA241927-01A1
Tissue-Engineered Models of Microvessel-Mediated Glioblastoma Invasion
National Institutes of Health
Grant: 5R03AG073929-02
Defining microvascular structure and function in the aged cervical spinal cord
National Institutes of Health
Grant: 5R01NS121191-04
Hemodynamic basis for secondary cervical grey matter tissue loss after spinal cord injury
Fields of Study
Keywords